| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 11018492 | Journal of Microbiology, Immunology and Infection | 2018 | 28 Pages |
Abstract
The patients who received treatment of ertapenem may have a lower risk of rectal colonization for ertapenem resistant Escherichia coli than those who received flomoxef or moxifloxacin. The rate of Pseudomonas colonization did not differ between the three study Pseudomonas-sparing agents.
Keywords
Related Topics
Life Sciences
Immunology and Microbiology
Immunology
Authors
Jen-Jia Yang, Jann-Tay Wang, Aristine Cheng, Yu-Chung Chuang, Wang-Huei Sheng,